RBC Capital Downgrades Allergen (AGN) to Outperform
Tweet
Share
E-mailGet Alerts AGN Hot Sheet
Price: $193.02 --0%
Rating Summary:
8 Buy, 20 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
8 Buy, 20 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
RBC Capital downgraded Allergen (NYSE: AGN) from Top Pick to Outperform with a price target of $361 (unchanged).
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $317.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades AAC Technologies Holdings Inc. (2018:HK) (AACAY) to Neutral
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- Deutsche Bank Downgrades Straumann Holding AG (STMN:SW) (SAUHF) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
